A bioluminescent-based probe for in vivo non-invasive monitoring of nicotinamide riboside uptake reveals a link between metastasis and NAD+ metabolism
- 29 October 2022
- journal article
- research article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 220, 114826
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Visualizing cellular interactions with a generalized proximity reporterProceedings of the National Academy of Sciences, 2013
- Cage the firefly luciferin! – a strategy for developing bioluminescent probesChemical Society Reviews, 2012
- Real-Time Noninvasive Imaging of Fatty Acid Uptake in VivoACS Chemical Biology, 2012
- The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced ObesityCell Metabolism, 2012
- From Mechanism to Mouse: A Tale of Two Bioorthogonal ReactionsAccounts of Chemical Research, 2011
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- Mechanism of nicotinic acid transport in human liver cells: experiments with HepG2 cells and primary hepatocytesAmerican Journal of Physiology-Cell Physiology, 2007
- Nicotinamide Is Not a Substrate of the Facilitative Hexose Transporter GLUT1Biochemistry, 2002
- Specific binding and uptake of extracellular nicotinamide in human leukemic k-562 cellsBiochemical Pharmacology, 1993
- Spectral emission and quantum yield of firefly bioluminescenceArchives of Biochemistry and Biophysics, 1960